Immunai

Immunai

Mapping the Immune System with AI to Improve Health

Location
Roles tracked
0
In pipeline
0
Tracking since

At a glance

You're tracking 0 roles at Immunai. Track a role to start building momentum here.

Company intel

From the job board · LinkedIn data via posting sync
Industry
Biotechnology Research
Company size
174 people
Headquarters
New York, NY
Founded
2019
Type
Privately Held
Total funding
$295.0M

Comprehensively mapping and decoding the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

immunology machine learning software engineering cancer high-dimensional statistics genomic technologies and single-cell biology

Open roles at Immunai